Tango Therapeutics, Inc. (TNGX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Tango Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -10.13x | -2.59x | -9.20x | -5.89x | -11.67x | -19.25x |
| P/B Ratio | 2.97x | 1.69x | 3.70x | 2.55x | 1.97x | 25.93x |
| P/S Ratio | 16.50x | 8.02x | 25.63x | 25.61x | 18.34x | 130.71x |
| Profitability | ||||||
| Gross Margin | 96.3% | 100.0% | 100.0% | 100.0% | 100.0% | 78.8% |
| Operating Margin | -178.4% | -346.1% | -312.6% | -446.8% | -157.1% | -681.8% |
| Net Margin | -162.9% | -309.7% | -278.5% | -435.1% | -157.2% | -678.8% |
| EBITDA Margin | -174.7% | -340.1% | -306.0% | -440.3% | -154.7% | -657.6% |
| Liquidity | ||||||
| Current Ratio | 16.32x | 6.98x | 7.54x | 6.76x | 12.10x | 4.73x |
| Quick Ratio | 16.32x | 6.98x | 7.54x | 6.76x | 12.10x | 4.73x |
| Leverage | ||||||
| Debt/Equity | 0.10x | 0.18x | 0.15x | 0.16x | 0.00x | 0.20x |
YoY = year-over-year change. Source: FMP..